Stanford
http://www.stanfordgroup.com/#Stanford provides institutional investment services and private wealth management services. The firm also offers equity research to its clients in the consumer, media, energy, financial, healthcare, technology and water/environment sectors.
View Older Stories View More Recent Stories
-
John C. Williams Named President and CEO of New York Fed
-
UPDATE: Genius Brands Int'l (GNUS) Publishes Shareholder Letter from Chairman & CEO Andy Heyward
-
Commerce Bancshares (CBSH) Reports CEO Succession Plan; President/COO John Kemper to Become CEO, Effective August 1, 2018
-
Grainger (GWW) Names Thomas Okray as CFO
-
Marissa Mayer joins Board of Directors at Lucile Packard Children's Hospital Stanford
-
ChromaDex (CDXC) Announces Published Results from Human Clinical Study of NIAGEN
-
Netflix, Inc. (NFLX) Names Susan E. Rice to Board
-
CarBlock Announces Formation of Advisory Board – Appointment of Members
-
Stanford GSB Black Business Conference Returns April 28
-
Second Sight Medical (EYES) Names John T. Blake as Chief Financial Officer
-
Jupiter Orphan Therapeutics, Inc. Adds Professor Gino Cortopassi, Ph.D. to Assist in The Company's Mitochondrial Disease Projects
-
Westport (WPRT) Appoints Michele Buchignani to Board
-
SMART Global Holdings, Inc. (SGH) Names Ajay Shah as CEO
-
Digital currency sales face rocky path with more regulatory focus
-
Innovate Biopharma (INNT) Appoints June Almenoff as COO and CMO
-
AmpliPhi Biosciences (APHB) Reports Agreement with U.S. Dept of Veteran Affairs to Expand Access for Investigational Bacteriophage Therapeutics AB-SA01 and AB-PA01
-
Crypto-Blockchain Venture Summit at Stanford
-
Fibrocell Science (FCSC) Announces FDA Allowance of IND for FCX-013 for Treatment of Moderate to Severe Localized Scleroderma
-
KKR & Co. (KKR) Names Xavier Niel to Board
-
Stanford GSB Launches a New Immersive Online Executive Education Certificate on Personal Leadership
-
CorMedix Inc. Granted Orphan Drug Designation for Taurolidine for Treatment of Neuroblastoma
-
Stanford Graduate School of Business Future of Media Conference Returns Wednesday, February 28
-
TEGNA (TGNA) Elects Howard Elias as New Chairman, Stuart Epstein as New Director
-
Eyenovia (EYEN) Advances MicroPine for Myopia into Phase III Clinical Development
-
Progress Software (PRGS) Appoints Sam King and Angela Tucci to Board
-
Lithuania's 100 Year Celebration Of Independence
-
Care.com (CRCM) Names Marla Blow and William H. Harris to Board
-
CAI International (CAI) Appoints Kathryn G. Jackson to Board
-
Stanford GSB Launches New Executive Education Program to Help Senior Leaders Harness Big Data in Their Organizations
-
Stanford Graduate School of Business Sports Innovation Conference Returns Wednesday, March 7, With All-Star Lineup
-
Pioneering immunotherapy to find and kill elusive cancer cells in children at Lucile Packard Children's Hospital Stanford
-
Dun & Bradstreet (DNB) Says Thomas Manning Named as Chairman and Interim CEO; Robert Carrigan to Step Down
-
Cytokinetics (CYTK) Names Robert Califf to Board of Directors
-
UPS (UPS) Appoints Christiana Smith Shi to Board
-
Walmart (WMT) Adds Square (SQ) CFO to Board
-
Upwork releases Q4 2017 Skills Index, ranking the 20 fastest-growing skills for freelancers
-
ExxonMobil (XOM) Announces Release of Energy & Carbon Summary, Outlook for Energy
-
TG Therapeutics (TGTX) Announces Updated Results from Ongoing Phase 2 Study of Ublituximab in Patients with MS at ACTRIMS
-
OraSure Technologies (OSUR) Names Aradhana Sarin M.D. to Board
-
Fibrocell Science (FCSC) Reports FDA Allowance to Initiate Pediatric Enrollment in Phase 1/2 Clinical Trial of FCX-007 for the Treatment of RDEB
-
Moody’s Corp. (MCO) CFO Linda S. Huber to Depart
-
Sotheby's (BID) Announces Acquisition of Thread Genius
-
Resources Connection (RECN) Announces Appointment of Kate Duchene to the Board of Directors
-
Reata Pharma (RETA) Announces Publication of Efficacy Data From the Beacon Study of Bardoxolone in Diabetic CKD
-
Starboard to Nominate Slate of Nine for Mellanox's (MLNX) Board
-
Triumph Group (TGI) Announces Appointment of Larry Spencer and Daniel Garton to Serve as Directors
-
Huggies Awards Four Additional $10,000 Grants to Support Hospital Hugging Programs and The Babies Who Benefit from Them
-
Eiger BioPharmaceuticals (EIGR) Reports Complete Enrollment of Phase 2 ULTRA Study of Ubenimex in Primary and Secondary Lymphedema Patients
-
Oncosec Medical (ONCS) Provides 2018 Business Outlook
-
IHS Markit (INFO) Names Two New Directors to its Board; Lance Uggla Assumes Role as Chairman and CEO

